These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7587827)

  • 21. Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study.
    Francois E; Smith D; Dahan L; Michel C; Perrier H; Mari V; Seitz JF; Follana P; Evesque L; Chamorey E
    J Chemother; 2012 Aug; 24(4):207-11. PubMed ID: 23040684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in patients with colorectal cancer who receive oral uracil and tegafur plus leucovorin.
    Tsunoda A; Nakao K; Watanabe M; Matsui N; Tsunoda Y
    Jpn J Clin Oncol; 2010 May; 40(5):412-9. PubMed ID: 20085907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete remission of multiple hepatocellular carcinomas associated with hepatitis C virus-related, decompensated liver cirrhosis by oral administration of enteric-coated tegafur/uracil.
    Ishikawa T; Ichida T; Ishimoto Y; Yokoyama J; Nomoto M; Ebe Y; Usuda H; Naito M; Asakura H
    Am J Gastroenterol; 1999 Jun; 94(6):1682-5. PubMed ID: 10364045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon Cancer.
    Kusumoto T; Sunami E; Ota M; Yoshida K; Sakamoto Y; Tomita N; Maeda A; Mochizuki I; Okabe M; Kunieda K; Yamauchi J; Itabashi M; Kotake K; Takahashi K; Baba H; Boku N; Aiba K; Ishiguro M; Morita S; Sugihara K
    Clin Colorectal Cancer; 2018 Jun; 17(2):e153-e161. PubMed ID: 29249584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective analysis of an oral combination of dexamethasone, uracil plus tegafur and cyclophosphamide for hormone-refractory prostate cancer.
    Hatano K; Nonomura N; Nishimura K; Kawashima A; Mukai M; Nagahara A; Nakai Y; Nakayama M; Takayama H; Tsujimura A; Okuyama A
    Jpn J Clin Oncol; 2011 Feb; 41(2):253-9. PubMed ID: 21071389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of severe enteritis induced by adjuvant chemotherapy for colon cancer].
    Mukai S; Endo S; Nakahara K; Takayanagi D; Maeda C; Takehara Y; Omoto T; Wada Y; Kida H; Hidaka E; Ishida F; Tanaka J; Kudo SE
    Gan To Kagaku Ryoho; 2014 Apr; 41(4):499-502. PubMed ID: 24743369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial.
    Yeh YS; Tsai HL; Huang CW; Wei PL; Sung YC; Tang HC; Wang JY
    Trials; 2017 Apr; 18(1):191. PubMed ID: 28441966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of stage IV colon cancer effectively treated with tegafur uracil/calcium folinate in a patient on hemodialysis].
    Okamoto K; Kobayashi M; Maeda H; Takeshita A
    Gan To Kagaku Ryoho; 2012 Jul; 39(7):1151-3. PubMed ID: 22790059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis.
    Kim SY; Baek JY; Oh JH; Park SC; Sohn DK; Kim MJ; Chang HJ; Kong SY; Kim DY
    Radiat Oncol; 2017 Mar; 12(1):62. PubMed ID: 28347333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The feasibility of oral fluoropyrimidines as adjuvant chemotherapy after resection and local coagulation therapy of colorectal liver metastases].
    Narita T; Seshimo A; Itabashi M; Aratake K; Ogawa S; Hirosawa T; Hashimoto T; Amano K; Kameoka S
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1821-4. PubMed ID: 22083190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent.
    Kono T; Ishii M; Negoro N; Taniguchi S
    J Am Acad Dermatol; 2000 Mar; 42(3):519-20. PubMed ID: 10688731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
    Takayama K; Kawasaki M; Ninomiya K; Motohiro A; Fujita M; Watanabe K; Kajiki A; Iwami F; Miyazaki N; Izumi M; Hara N; Nakanishi Y;
    Respirology; 2008 Jan; 13(1):103-7. PubMed ID: 18197918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma.
    Hsu CH; Shen YC; Lin ZZ; Chen PJ; Shao YY; Ding YH; Hsu C; Cheng AL
    J Hepatol; 2010 Jul; 53(1):126-31. PubMed ID: 20416968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [UFT].
    TakuchiT
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1692-6. PubMed ID: 6433802
    [No Abstract]   [Full Text] [Related]  

  • 35. A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics.
    Boku N; Ohtsu A; Muro K; Kaneko K; Muto M; Ohkuwa M; Ishii H; Sasaki Y; Tajiri H; Yoshida S; Kusada O
    Jpn J Clin Oncol; 1996 Oct; 26(5):379-83. PubMed ID: 8895681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
    Sato Y; Inaba Y; Yamaura H; Shimamoto H; Nishiofuku H; Oyama T; Kanemitsu Y; Sawaki A; Arai Y; Muro K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):887-90. PubMed ID: 16835473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects and side effects of long-term administration of oral antitumor agents in patients with hepatocellular carcinoma--especially, relation to aggravation of liver function].
    Ikeda K; Kumada H; Arase Y; Nakamura I; Chayama K; Murashima N; Takeuchi K; Nakajima M; Yoshiba A; Irimoto M
    Nihon Shokakibyo Gakkai Zasshi; 1987 Oct; 84(10):2377-85. PubMed ID: 2830421
    [No Abstract]   [Full Text] [Related]  

  • 38. Toxicity and Efficacy of Sequential Chemotherapy in Patients with p-stage I Non-small Cell Lung Cancer that Recurring during Postoperative Tegafur-Uracil Adjuvant Chemotherapy.
    Kashiwabara K; Semba H; Fujii S; Tsumura S
    Cancer Invest; 2018; 36(8):424-430. PubMed ID: 30234395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
    Hong KD; Lee SI; Moon HY
    Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase I study of concurrent chemoradiotherapy and cetuximab for locally advanced esophageal cancer.
    Holländer C; Baeksgaard L; Sorensen M; Albertsson P; Damstrup L; Lassen U
    Anticancer Res; 2012 Sep; 32(9):4019-23. PubMed ID: 22993353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.